Top Markets
#1 OriginTrail OriginTrail +34.00%
#2 Tutorial Tutorial +12.08%
#3 MarsCoin MarsCoin +11.70%
#4 Waves Waves +10.84%
#5 Pons Pons +8.58%
#6 Siren Siren +8.36%
#7 Synapse Synapse +7.21%
#8 Cortex Cortex +7.15%
#9 Euler Euler +6.25%
#10 TROLL TROLL +6.08%
Coin of the day
OriginTrail OriginTrail
Settings
Language
ENGLISH
Currency
USD
Theme
Allied Biotech Corporation Allied Biotech Corporation

Allied Biotech Corporation

1780
Rank in Stocks #22532
Allied Biotech Corporation operates as a global producer and supplier... Allied Biotech Corporation operates as a global producer and supplier specializing in carotenoids. The company's diverse product portfolio features key carotenoids such as: Beta-Carotene, known for imparting vibrant yellow to reddish-orange hues across numerous applications. Beta-Apo-8'-Carotenal, a versatile food colorant delivering shades from rich orange to deep red. Lycopene, a valuable nutrient that provides striking red tones for incorporation into food, dietary supplements, and pharmaceutical formulations. Canthaxanthin, which contributes reddish-orange colors specifically to food and beverage products. Lutein, another carotenoid frequently derived from or associated with green leafy vegetables (like spinach, kale, and broccoli) and egg yolks. Additionally, Allied Biotech offers Nano Coenzyme Q10, an antioxidant crucial for cellular energy production. The corporation caters to a diverse clientele across the food, beverage, dietary supplement, and animal feed sectors. Established in 2001, Allied Biotech Corporation maintains its headquarters in Taipei, Taiwan.
Share Price
$0.7981556
Last synced: 2026-08-21
Market Cap
$87.06M
Change (1 day)
0.40%
Change (1 year)
38.97%
Country
TW
Trade Allied Biotech Corporation (1780)

Category

Healthcare
P/E ratio for Allied Biotech Corporation (1780)
P/E ratio as of 2026 TTM: 0
According to Allied Biotech Corporation latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Allied Biotech Corporation from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 38.29 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.